Chairman Guthrie Writes to Columbia University Amid Concerns Over How the University is Combatting Antisemitism
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, sent a letter to Columbia University Acting President Claire Shipman questioning the university's compliance with federal anti-discrimination laws—particularly Title VI of the Civil Rights Act. The letter comes amid growing concerns that Columbia, which receives Medicare and Medicaid reimbursements and got $690 million+ in National Institutes of Health (NIH) grants in FY2024 , has repeatedly failed to protect Jewish students, faculty, and patients from antisemitic harassment and discrimination, even though Columbia is required to do so as a recipient of federal funds and under the July 2025 agreement with the U.S. government. Some of the most glaring examples of deficiencies in Columbia’s attitude toward mitigating antisemitism that have raised concerns include: Withholding information from a court-appointed federal Resolution Monitor; Deposition testimony of the former Acting President (now the Chief Executive Officer (CEO) of Columbia Medical); A failing grade in a national December 2025 campus antisemitism report ; and A broader culture of antisemitism potentially exacerbated by New York City Mayor Zohran Mamdani’s recent reversal of the city’s adoption of the International Holocaust Remembrance Alliance (IHRA) definition of antisemitism. Chairman Guthrie issued the following statement in response to the Committee’s findings: “The Committee is troubled by recent reports and allegations raising questions about Columbia University’s willingness to uphold its commitments to protect Jewish students, faculty, and staff,” said Chairman Guthrie. “The fact that Columbia receives hundreds of millions of dollars from HHS and its subagencies, coupled with the serious concerns regarding its compliance with federal anti-discrimination laws, demonstrates that further oversight is needed. This Committee will continue to hold such institutions accountable that repeatedly foster environments of discrimination and harassment.” BACKGROUND: In May 2024, the House Committee on Energy and Commerce and the Committee on Education and the Workforce opened investigations into the extent to which HHS and NIH are ensuring that institutions receiving hundreds of millions of taxpayer dollars from HHS or NIH are complying with relevant federal civil rights laws and are providing safe environments for all, particularly those individuals of Jewish ancestry. In September 2024, the Committees launched investigations into incidents of antisemitism at three NIH-funded institutions, including Columbia University, as well as their medical schools and associated health care systems, and the Gladstone Institutes, an independent research institution. In October 2024, the Committees also opened investigations into the Advanced Research Projects Agency for Health (ARPA-H), an independent agency within NIH that has funded more than $595 million in biomedical and health research at institutions and organizations in 2024. The Committees’ investigation found that HHS, NIH, and HHS OCR failed to act in the wake of emerging antisemitism across college campuses, medical schools, and medical systems. Prior HHS leadership refused to cooperate with congressional inquiries into their actions—or lack thereof—or require federal taxpayer-funded institutions to comply with civil rights laws and prevent antisemitism at their institutions. Today, the Committee is requesting that Columbia provide a comprehensive accounting of discrimination and harassment complaints, investigations, and outcomes since January 2023, including: Specific reporting of how many complaints involved antisemitism and how many were related or connected to individuals or institutions at Columbia that received NIH-funded grants; Details on the role and level of engagement in anti-discrimination compliance oversight of Dr. Katrina Armstrong, CEO of the Columbia University Irving Medical Center; and Information on how Columbia protects and supports victims of violations of federal anti-discrimination laws, including anonymous complainants, and whether tenure can be revoked for substantiated violations of federal anti-discrimination laws. CLICK HERE to read the full letter.